UnitedHealth Group has agreed to buy Catamaran in a transaction worth approximately $12.8 billion, in order to improve its pharmacy benefits operations (OptumRx). The transaction will add approximately $0.30 per share to UnitedHealth’s profit in 2016 and is expected to close in Q4 2015.
Market Pulse transactions shown herein are provided as a matter of public record. These transactions have been compiled from press releases, corporate announcements and other public sources to provide an overview of acquisition and merger activities within the healthcare and life sciences sectors.